Cargando…
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases
Interstitial lung diseases (ILDs) include a large number of diseases and causes with variable outcomes often associated with progressive fibrosis. Although each of the individual fibrosing ILDs are rare, collectively, they affect a considerable number of patients, representing a significant burden o...
Autores principales: | Tanguy, Julie, Pommerolle, Lenny, Garrido, Carmen, Kolb, Martin, Bonniaud, Philippe, Goirand, Françoise, Bellaye, Pierre-Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430559/ https://www.ncbi.nlm.nih.gov/pubmed/34502225 http://dx.doi.org/10.3390/ijms22179316 |
Ejemplares similares
-
HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling
por: Tanguy, Julie, et al.
Publicado: (2023) -
Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin
por: Burgy, Olivier, et al.
Publicado: (2016) -
[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach
por: Tanguy, Julie, et al.
Publicado: (2021) -
Heat Shock Proteins: Cell Protection through Protein Triage
por: Lanneau, David, et al.
Publicado: (2010) -
The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)